Biotech company focused on the development of new therapies
Advanced clinical stage biotechnology focused on the development of new therapies for orphan and severe genetic diseases of the central nervous system with high unmet medical need such as AML or cALD.
CEO: Marc Martinell.
Av. Ernest Lluch 32 – TCM3
08302 Mataró (Barcelona), España